Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.cnn.com › 2023/06/26 › healthNext-generation drug from Eli Lilly boosts weight loss to 24% ......

   www.cnn.com › 2023/06/26 › health

   • Αποθηκευμένο αντίγραφο

   Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.

2. www.fda.gov › fda-approves-new-medication-chronic-weight-managementFDA Approves New Medication for Chronic Weight Management

   www.fda.gov › fda-approves-new-medication-chronic-weight-management

   • Αποθηκευμένο αντίγραφο

   Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/...

3. www.nytimes.com › 2023/11/08 › healthF.D.A. Approves New Obesity Drug That Will Compete With Wegovy

   www.nytimes.com › 2023/11/08 › health

   8 Νοε 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy. The drug is called tirzepatide and...

4. www.medscape.com › viewarticle › new-oral-weight-loss-drugs-where-are-we-and-whatsNew Oral Weight Loss Drugs: Where Are We and What's Next? -...

   www.medscape.com › viewarticle › new-oral-weight-loss-drugs-where-are-we-and-whats

   • Αποθηκευμένο αντίγραφο

   5 Ιουν 2024 · The company also announced that the US Food and Drug Administration has approved an expansion of the trial's protocol to investigate the contribution of circadian effects in weight loss...

5. www.fda.gov › news-events › press-announcementsFDA Approves New Drug Treatment for Chronic Weight Management,...

   www.fda.gov › news-events › press-announcements

   • Αποθηκευμένο αντίγραφο

   FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.

6. www.cnn.com › 2023/11/08 › healthFDA approves Eli Lilly’s diabetes drug Mounjaro for obesity ... -...

   www.cnn.com › 2023/11/08 › health

   • Αποθηκευμένο αντίγραφο

   8 Νοε 2023 · The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed...

7. www.fda.gov › fdas-concerns-unapproved-glp-1-drugs-used-weight-lossFDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

   www.fda.gov › fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

   • Αποθηκευμένο αντίγραφο

   2 Οκτ 2024 · Complete and submit the report online, or. Download and complete the form, then submit it via fax at 1-800-FDA-0178. You also may contact the CDER Division of Drug Information at druginfo@fda.hhs ...